The strategic framework of tuberculosis control and prevention in the elderly: A scoping review towards End TB targets

Infectious Diseases of Poverty

Volumn 6, Issue 1, 2017, Pages

  Li, Jun ^a   Chung, Pui Hong ^a   Leung, Cyrus L K ^a   Nishikiori, Nobuyuki ^b   Chan, Emily Y Y ^a   Yeoh, Eng Kiong ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Aged older people; Prevention and control of infectious disease; Scoping review; Strategy; Tuberculosis

Indexed keywords

BACTERIAL TRANSMISSION; BIBLIOGRAPHIC DATABASE; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MIGRATION; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SOCIAL STATUS; TUBERCULOSIS; AGED; LEGISLATION AND JURISPRUDENCE; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; HEALTH POLICY; HUMANS; MIDDLE AGED; TUBERCULOSIS;

EID: 85020008360     PISSN: None     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/s40249-017-0284-4     Document Type: Review

References (71)

1. World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015.
2. World Health Organization. WHO End TB Strategy. 2014. [ http://www.who.int/tb/post2015_strategy/en/ ]. Accessed 17 Oct 2016.
3. Lonnroth K, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375(9728):1814-29.
4. World Health Organization. Ageing and health. 2015. [ http://www.who.int/mediacentre/factsheets/fs404/en/ ]. Accessed 17 Oct 2016.
5. World Health Organization. What are the public health implications of global ageing? 2011. [ http://www.who.int/features/qa/42/en/ ]. Accessed 17 Oct 2016.
6. Mori T, Leung CC. Tuberculosis in the global aging population. Infect Dis Clin N Am. 2010;24(3):751-68.
7. Tocque K, et al. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and wales. Am J Respir Crit Care Med. 1998;158(2):484-8.
8. Bennett DE, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348-55.
9. Ohmori M, et al. Current epidemiological trend of tuberculosis in Japan. Int J Tuberc Lung Dis. 2002;6(5):415-23.
10. Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults time to take notice. Int J Infect Dis. 2015;32:135-7.
11. Wang L, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057-64.
12. Ananthakrishnan R, et al. The profile and treatment outcomes of the older (aged 60 years and above) tuberculosis patients in Tamilnadu, South India. PLoS One. 2013;8(7):e67288.
13. Van Den Brande P. Strategies for managing tuberculosis in older patients. London: Future medicine Ltd.; 2006. p. 851-64.
14. World Health Organization. WHO guidelines on tuberculosis. 2016. [ http://www.who.int/publications/guidelines/tuberculosis/en/ ]. Accessed 17 Oct 2016.
15. Huynh GH, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. Bmc Medicine. 2015;13:88.
16. Vynnycky E, et al. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol Infect. 2008;136(7):943-52.
17. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19-32.
18. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-88.
19. Van den Brande P. Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly. Drugs Aging. 2005;22(8):663-86.
20. Walsh K. Guidelines for the prevention and control of tuberculosis in the elderly. Nurse Pract. 1994;19(11):79-84.
21. CDC. Prevention and control of tuberculosis in facilities providing long-term care to the elderly. Recommendations of the advisory committee for elimination of tuberculosis. MMWR Recomm Rep. 1990;39(10):7-13.
22. Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001;33(7):1034-9.
23. Rajagopalan S, Yoshikawa TT. Tuberculosis in the elderly. Z Gerontol Geriatr. 2000;33(5):374-80.
24. Gubser VL. Tuberculosis and the elderly. A community health perspective. J Gerontol Nurs. 1998;24(5):36-41.
25. Rajagopalan S, Yoshikawa TT. Tuberculosis in long-term-care facilities. Infect Control Hosp Epidemiol. 2000;21(9):611-5.
26. Thrupp L, et al. Tuberculosis prevention and control in long-term-care facilities for older adults. Infect Control Hosp Epidemiol. 2004;25(12):1097-108.
27. Schaaf HS, et al. Tuberculosis at extremes of age. Respirology. 2010;15(5):747-63.
28. Zevallos M, Justman JE. Tuberculosis in the elderly. Clin Geriatr Med. 2003;19(1):121-38.
29. Ghotbi N, Nishimura S, Takatsuka N. Japan's national tuberculosis control strategies with economic considerations. Environ Health Prev Med. 2005;10(4):213-8.
30. Verma G, Chuck AW, Jacobs P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2013;17(9):1170-7.
31. Kowada A, et al. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations. Mol Diagn Ther. 2010;14(4):229-36.
32. Marchand R, Tousignant P, Chang H. Cost-effectiveness of screening compared to case-finding approaches to tuberculosis in long-term care facilities for the elderly. Int J Epidemiol. 1999;28(3):563-70.
33. Zhang XL, et al. Integrating tuberculosis screening into annual health examinations for the rural elderly improves case detection. Int J Tuberc Lung Dis. 2015;19(7):787-91.
34. Mirsaeidi M, et al. Management of nontuberculous mycobacterial infection in the elderly. Eur J Intern Med. 2014;25(4):356-63.
35. Bentley DW. Tuberculosis in long-term care facilities. Infect Control Hosp Epidemiol. 1990;11(1):42-6.
36. National bureau of Statistics of China. The main data bulletin of 6th national population census in 2010 in China (Number one). [ http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/201104/t20110428_30327.html ]. Accessed 17 Oct 2016.
37. Technical Guidance Group of the Fifth National TB Epidemiological Survey, The Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberculosis. 2012;34(8):485-508.
38. Eang MT, et al. Early detection of tuberculosis through community-based active case finding in Cambodia. BMC Public Health. 2012;12:469.
39. Santha T, et al. Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. Int J Tuberc Lung Dis. 2003;7(3):258-65.
40. Cassels A, et al. Tuberculosis case-finding in Eastern Nepal. Tubercle. 1982;63(3):175-85.
41. World Health Orgnization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015.
42. Kopanoff DE, Snider Jr DE, Caras GJ. Isoniazid-related hepatitis: a U.S. Public health service cooperative surveillance study. Am Rev Respir Dis. 1978;117(6):991-1001.
43. Sorresso DJ, et al. Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis. Chest. 1995;108(3):706-11.
44. Rose DN, Schechter CB, Silver AL. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. JAMA. 1986;256(19):2709-13.
45. Gray EL, Goldberg HF. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection. Intern Med J. 2016;46(3):281-7.
46. Kunst H, Khan KS. Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review. Int J Tuberc Lung Dis. 2010;14(11):1374-81.
47. Lee AM, et al. Risk factors for hepatotoxicity associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: experience from three public health tuberculosis clinics. Int J Tuberc Lung Dis. 2002;6(11):995-1000.
48. Department of Health, Government of the HKSAR. Tuberculosis manual. Hong Kong: Department of Health, Government of the HKSAR; 2006.
49. Powell KE, Farer LS. The rising Age of the tuberculosis patient: a sign of success and failure. J Infect Dis. 1980;142(6):946-8.
50. Wu P, et al. The transmission dynamics of tuberculosis in a recently developed Chinese city. PLoS ONE. 2010;5(5):e10468.
51. Golub JE, et al. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis. 2005;9(11):1183-203.
52. Lonnroth K, et al. Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis. 2013;17(3):289-98.
53. World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization; 2013.
54. Perez-Guzman C, et al. Does aging modify pulmonary tuberculosis?: A meta-analytical review. Chest. 1999;116(4):961-7.
55. Leung CC, et al. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc. 2002;50(7):1219-26.
56. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. Plos Med. 2008;5(7):1091-101.
57. Kirkman MS, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650-64.
58. Jeon CY, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Tropical Med Int Health. 2010;15(11):1300-14.
59. Schluger NW. Tuberculosis and nontuberculous mycobacterial infections in older adults. Clin Chest Med. 2007;28(4):773-81. vi.
60. Morris CD. Pulmonary tuberculosis in the elderly: a different disease? Thorax. 1990;45(12):912-3.
61. Salvadó M, et al. Mortality of tuberculosis in very Old people. J Am Geriatr Soc. 2010;58(1):18-22.
62. Lin YS, Yen YF. Determinants of mortality before start of and during tuberculosis treatment among elderly patients: a population-based retrospective cohort study. Age Ageing. 2015;44(3):490-6.
63. Stead WW, et al. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med. 1985;312(23):1483-7.
64. Chan-Yeung M, et al. Tuberculin skin test reaction and body mass index in old age home residents in Hong Kong. J Am Geriatr Soc. 2007;55(10):1592-7.
65. Woo J, et al. Tuberculosis among elderly Chinese in residential homes: tuberculin reactivity and estimated prevalence. Gerontology. 1996;42(3):155-62.
66. Chan-Yeung M, et al. Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong. J Am Geriatr Soc. 2006;54(9):1334-40.
67. LoBue PA, Catanzaro A. Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. Chest. 1998;113(5):1184-9.
68. Jensen PA, Lambert LA, Iademarco MF, et al. CDC Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1-141.
69. Zwerling A, et al. Modeling of Novel Diagnostic Strategies for Active Tuberculosis - A Systematic Review: Current Practices and Recommendations. Plos One. 2014;9(10):e110558.
70. Nienhaus A, et al. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011;11(1):1-10.
71. Campbell JR, Sasitharan T, Marra F. A systematic review of studies evaluating the cost utility of screening high-risk populations for latent tuberculosis infection. Appl Health Econ Health Policy. 2015;13(4):325-40.